Opinion · 19 Sep 2025
Conference abstractPublished 18 Oct 2017
Efficacy, safety and dose finding trial of topical Jaungo application in atopic dermatitis patients: A randomized, double-blind, placebo-controlled study
CY Pharmaceutical Co, Ltd, Republic of Korea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atopic Dermatitis (AD) is a common pruritic inflammatory skin disease. In its chronic stage, hyperpigmentation, excoriation, lichenification and dryness are the main symptoms. Jaungo comprises two herbs, Lithospermi Radix and Angelica Gigantis Radix and three carrier oils and is an approved herbal ointment for xerosis in Korea. In past preclinical studies, we demonstrated that Jaungo had anti-inflammatory and anti-allergic activity. We conducted a randomized, double blind, placebo-controlled, single-center trial with three parallel arms. Trial group-1 applies Jaungo twice a day, while trial group-2 applies Jaungo and the placebo once a day, separately, and the placebo group applies the placebo twice a day, for a total of 3 weeks each. Participants evaluated for eczema based on the eczema area and severity score, the scoring of atopic dermatitis score, the dermatology life quality score, trans-epidermal water loss, total IgE level, eosinophil count and IL-17, IL-22 and IFN-Ã?³ levels. The outcomes to evaluate the safety included Draize score and blood test. In total, 28 patients (82.4%) completed the study. Significant decline of EASI scores in trial group-2 and placebo group was observed (p<0.05). There was significant decline of SCORAD scores in trial group-1 and placebo group (p<0.05). However, patients in all groups showed decreased TEWL and DLQI scores with no significant difference. No clinically relevant changes in laboratory values were observed except IL-17. There was significant decline of IL-17 in all groups (p<0.05). Inter-group analysis showed no significant difference. No serious adverse event was observed.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal & Aromatic Plants.
Perspective · 18 Sep 2025
Bioactive Compounds from Medicinal Plants and Their Therapeutic Applications
Perspective · 18 Sep 2025
Conservation Strategies for Endangered Medicinal Plant Species
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal & Aromatic Plants
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Younghee Yun”
